Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
Current Medical Research and Opinion|July 1, 2017
Association between rivaroxaban use and length of hospital stay, treatment costs and early outcomes in patients with pulmonary embolism: a systematic review of real-world studiesChristine G Kohn, Gregory J Fermann, W Frank Peacock, et al.
Internal and Emergency Medicine|October 21, 2016
Hospital length-of-stay and costs among pulmonary embolism patients treated with rivaroxaban versus parenteral bridging to warfarinErin R Weeda, Philip S Wells, W Frank Peacock, et al.
Journal of Thrombosis and Thrombolysis|June 22, 2016
Outcomes associated with observation stays versus inpatient admissions for pulmonary embolismErin R Weeda, W Frank Peacock, Gregory J Fermann, et al.
International Journal of Clinical Practice|January 19, 2017
Shortened hospital length of stay and lower costs associated with rivaroxaban in patients with pulmonary embolism managed as observation statusErin R Weeda, W Frank Peacock, Gregory J Fermann, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|August 3, 2016
Is Rivaroxaban Associated With Shorter Hospital Stays and Reduced Costs Versus Parenteral Bridging to Warfarin Among Patients With Pulmonary Embolism?Craig I Coleman, Gregory J Fermann, Erin R Weeda, et al.
Research and Practice in Thrombosis and Haemostasis|September 27, 2023
Lower mortality with andexanet alfa vs 4-factor prothrombin complex concentrate for factor Xa inhibitor-related major bleeding in a U.S. hospital-based observational studyPaul P Dobesh, Gregory J Fermann, Mary J Christoph, et al.
Annals of Emergency Medicine|October 19, 2010
Reperfusion is delayed beyond guideline recommendations in patients requiring interhospital helicopter transfer for treatment of ST-segment elevation myocardial infarctionJason T McMullan, William Hinckley, Jared Bentley, et al.
Heart Failure Reviews|December 14, 2011
Early changes in clinical characteristics after emergency department therapy for acute heart failure syndromes: identifying patients who do not respond to standard therapySean P Collins, Christopher J Lindsell, Alan B Storrow, et al.
Internal and Emergency Medicine|February 11, 2017
External validation of a claims-based and clinical approach for predicting post-pulmonary embolism outcomes among United States veteransChristine G Kohn, Erin R Weeda, Neela Kumar, et al.
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine|December 24, 2010
The role of the Society for Academic Emergency Medicine in the development of guidelines and performance measuresJesse M Pines, Christopher Fee, Gregory J Fermann, et al.
Pageof 8